<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">34228313</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2520-8721</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Hormones (Athens, Greece)</Title>
          <ISOAbbreviation>Hormones (Athens)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Oxyphil cells in primary hyperparathyroidism: a clinicopathological study.</ArticleTitle>
        <Pagination>
          <StartPage>715</StartPage>
          <EndPage>721</EndPage>
          <MedlinePgn>715-721</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s42000-021-00305-2</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of oxyphil cells (OxC) in primary hyperparathyroidism (PHPT) still remains controversial. Historically, they were believed to be involuted cells. However, they could play an important role in hormone secretion. The clinical behavior of OxC-rich adenomas and preoperative PHPT localization tests have been widely studied. The aim of this study is to analyze the implications of OxC in PHTP.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study of patients undergoing parathyroidectomy for PHPT was conducted. Additionally, we included normal glands removed in the context of PHPT or inadvertently during a thyroidectomy. All glands were reviewed independently by three researchers, performing a semi-quantitative analysis of the percentage of OxC. Groups with &lt; 25% OxC and &gt; 75% OxC were compared.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the period 2010-2017, 238 patients and 261 removed glands were included (8.8% OxCA &gt; 75%). There were no differences in symptomatology and levels of preoperative calcium, parathormone, or 25-OH vitamin. Patients with OxCA &gt; 75% had worse preoperative glomerular filtration rate (81.2 vs. 69.7 mL/min/1.73 m<sup>2</sup>; p = 0.043). They also had a trend towards larger size and weight (17 vs. 20 mm, p = 0.135 and 562 vs. 875 mg, p = 0.495), while ultrasound was found to have better accuracy (48.3% vs. 73.7%; p = 0.035). There were no normal glands with a content of OxC &gt; 75%.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study suggests that phosphocalcic metabolism is not influenced by the presence of a high content of OxC in the parathyroid glands. A high content of OxC seems to be exclusive to pathologic glands and could be related to the deterioration of renal function in patients with PHPT.</AbstractText>
          <CopyrightInformation>© 2021. Hellenic Endocrine Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De la Hoz Rodríguez</LastName>
            <ForeName>Ángela</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz De Nova</LastName>
            <ForeName>José Luis</ForeName>
            <Initials>JL</Initials>
            <Identifier Source="ORCID">0000-0003-1439-5632</Identifier>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz Hernández</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Department, Hospital Universitario de La Princesa, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valdés de Anca</LastName>
            <ForeName>Álvaro</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Serrano Pardo</LastName>
            <ForeName>Rosario</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Department, Hospital Universitario de La Princesa, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tovar Pérez</LastName>
            <ForeName>Rodrigo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín-Pérez</LastName>
            <ForeName>Elena</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Hormones (Athens)</MedlineTA>
        <NlmUniqueID>101142469</NlmUniqueID>
        <ISSNLinking>1109-3099</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049950" MajorTopicYN="Y">Hyperparathyroidism, Primary</DescriptorName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024862" MajorTopicYN="Y">Oxyphil Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010280" MajorTopicYN="N">Parathyroid Glands</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016105" MajorTopicYN="N">Parathyroidectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Oxyphil cells</Keyword>
        <Keyword MajorTopicYN="N">Parathyroid gland</Keyword>
        <Keyword MajorTopicYN="N">Primary hyperparathyroidism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>13</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34228313</ArticleId>
        <ArticleId IdType="doi">10.1007/s42000-021-00305-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s42000-021-00305-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamasurg.2016.2310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welsh DA (1898) Concerning the parathyroid glands: a critical anatomical and experimental study. J Anat Physiol 32:380-402.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17232318</ArticleId>
            <ArticleId IdType="pmc">1327899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castleman B, Mallory TB (1935) The pathology of the parathyroid gland in hyperparathyroidism. Am J Pathol 11:1–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19970186</ArticleId>
            <ArticleId IdType="pmc">1910762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGregor DH, Lotuaco LG, Rao MS, Chu LL (1978) Functioning oxyphil adenoma of parathyroid gland. An ultrastructural and biochemical study. Am J Pathol 92(3):691–711</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">686153</ArticleId>
            <ArticleId IdType="pmc">2018274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christie AC (1967) The parathyroid oxyphil cells. J clin Path 20:591</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.20.4.591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremblay G, Cartier GE (1961) Histochemical study of oxidative enzymes in the human parathyroid. Endocrinol 69:658–61</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endo-69-3-658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen TB, Thorburn KM (1981) The oxyphil cell in abnormal parathyroid glands. Arch Pathol Lab Med 105:421–427</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6894851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritter CS, Haughey BH, Miller B, Brown AJ (2012) Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 97(8):1499–1505</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2011-3366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howson P, Kruijff S, Aniss A, Pennington T, Gill AJ, Dodds T et al (2015) Oxyphil cell parathyroid adenomas causing primary hyperparathyroidism: a clinico-pathological correlation. Endocr Pathol 26(3):250–254</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12022-015-9378-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 34(1):24–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8418265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ et al (1998) Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 39(8):1441–1444</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9708524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erbil Y, Kapran Y, Işsever H, Barbaros U, Adalet I, Dizdaroǧlu F et al (2008) The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 195(1):34–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjsurg.2007.01.040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takebayashi S, Hidai H, Chiba T, Takagi Y, Nagatani Y, Matsubara S (1999) Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40(11):1792–1797</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10565772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S et al (1997) Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 24(2):143–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02439546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedetti CD, Dekker A, Watson CG (1984) Functioning oxyphil cell adenoma of the parathyroid gland: a clinicopathologic study of ten patients with hyperparathyroidism. Hum Pathol 15(12):1121–6. https://doi.org/10.1016/S0046-8177(84)80306-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0046-8177(84)80306-8</ArticleId>
            <ArticleId IdType="pubmed">6389314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolpert HR, Vickery AL, Wang CA (1989) Functioning oxyphil adenomas. Am J Surg Pathol 13(6):500–504</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000478-198906000-00006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta NY, Ruda JM, Kapadia S, Boyer PJ, Hollenbeak CS, Stack BC (2005) Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol - Head Neck Surg 131(6):493–498</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archotol.131.6.493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30(5):697–704</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00268-005-0338-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ (2012) Distribution and regulation of the 25-hydroxyvitamin D 3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 130(1–2):73–80. https://doi.org/10.1016/j.jsbmb.2012.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2012.01.010</ArticleId>
            <ArticleId IdType="pubmed">22326730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westreich RW, Brandwein M, Mechanick JI, Bergman DA, Urken ML (2003) Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope 113(3):567–572</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005537-200303000-00032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishibashi M, Nishida H, Strauss HW, Kojima K, Fujito H, Watanabe J (1997) Localization of parathyroid glands using technetium-99m-tetrofosmin imaging. J Nucl Med 38(5):706–711</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9170432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28(2):209–213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002590000406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bleier BS, LiVolsi VA, Chalian AA, Gimotty PA, Botbyl JD, Weber RS (2006) Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol - Head Neck Surg 132(7):779–782</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archotol.132.7.779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD et al (2007) Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 142(4):381–386</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archsurg.142.4.381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y et al (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139(11):1175–1179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archsurg.139.11.1175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cermik TF, Puyan FO, Sezer A, Firat MF, Berkarda S (2005) Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med 19(5):387–392</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03027403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dugonjić S, Cerović S, Janković Z, Ajdinović B (2012) Korelacija nalaza suptrakcione scintigrafije paratiroidnih žlezda liposolubilnim radiofarmacima sa veličinom, patohistološkim nalazom i procentom oksifilnih ćelija kod bolesnika sa hiperplazijom paratiroidnih žlezda. Vojnosanit Pregl 69(4):345–352</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2298/VSP1204345D</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundgren E, Ridefelt P, Åkerström G, Ljunghall S, Rastad J (1996) Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening. World J Surg 20(7):727–735</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002689900111</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">34228313</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2520-8721</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Hormones (Athens, Greece)</Title>
          <ISOAbbreviation>Hormones (Athens)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Oxyphil cells in primary hyperparathyroidism: a clinicopathological study.</ArticleTitle>
        <Pagination>
          <StartPage>715</StartPage>
          <EndPage>721</EndPage>
          <MedlinePgn>715-721</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s42000-021-00305-2</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of oxyphil cells (OxC) in primary hyperparathyroidism (PHPT) still remains controversial. Historically, they were believed to be involuted cells. However, they could play an important role in hormone secretion. The clinical behavior of OxC-rich adenomas and preoperative PHPT localization tests have been widely studied. The aim of this study is to analyze the implications of OxC in PHTP.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study of patients undergoing parathyroidectomy for PHPT was conducted. Additionally, we included normal glands removed in the context of PHPT or inadvertently during a thyroidectomy. All glands were reviewed independently by three researchers, performing a semi-quantitative analysis of the percentage of OxC. Groups with &lt; 25% OxC and &gt; 75% OxC were compared.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the period 2010-2017, 238 patients and 261 removed glands were included (8.8% OxCA &gt; 75%). There were no differences in symptomatology and levels of preoperative calcium, parathormone, or 25-OH vitamin. Patients with OxCA &gt; 75% had worse preoperative glomerular filtration rate (81.2 vs. 69.7 mL/min/1.73 m<sup>2</sup>; p = 0.043). They also had a trend towards larger size and weight (17 vs. 20 mm, p = 0.135 and 562 vs. 875 mg, p = 0.495), while ultrasound was found to have better accuracy (48.3% vs. 73.7%; p = 0.035). There were no normal glands with a content of OxC &gt; 75%.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study suggests that phosphocalcic metabolism is not influenced by the presence of a high content of OxC in the parathyroid glands. A high content of OxC seems to be exclusive to pathologic glands and could be related to the deterioration of renal function in patients with PHPT.</AbstractText>
          <CopyrightInformation>© 2021. Hellenic Endocrine Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De la Hoz Rodríguez</LastName>
            <ForeName>Ángela</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz De Nova</LastName>
            <ForeName>José Luis</ForeName>
            <Initials>JL</Initials>
            <Identifier Source="ORCID">0000-0003-1439-5632</Identifier>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain. jmunoz@salud.madrid.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz Hernández</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Department, Hospital Universitario de La Princesa, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valdés de Anca</LastName>
            <ForeName>Álvaro</ForeName>
            <Initials>Á</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Serrano Pardo</LastName>
            <ForeName>Rosario</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pathology Department, Hospital Universitario de La Princesa, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tovar Pérez</LastName>
            <ForeName>Rodrigo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín-Pérez</LastName>
            <ForeName>Elena</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>General Surgery Department, Hospital Universitario de La Princesa, C/Diego de Leon 62, 4th Floor, 28006, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universidad Autónoma de Madrid (UAM), Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Hormones (Athens)</MedlineTA>
        <NlmUniqueID>101142469</NlmUniqueID>
        <ISSNLinking>1109-3099</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049950" MajorTopicYN="Y">Hyperparathyroidism, Primary</DescriptorName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024862" MajorTopicYN="Y">Oxyphil Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010280" MajorTopicYN="N">Parathyroid Glands</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016105" MajorTopicYN="N">Parathyroidectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Oxyphil cells</Keyword>
        <Keyword MajorTopicYN="N">Parathyroid gland</Keyword>
        <Keyword MajorTopicYN="N">Primary hyperparathyroidism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>13</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34228313</ArticleId>
        <ArticleId IdType="doi">10.1007/s42000-021-00305-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s42000-021-00305-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamasurg.2016.2310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welsh DA (1898) Concerning the parathyroid glands: a critical anatomical and experimental study. J Anat Physiol 32:380-402.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17232318</ArticleId>
            <ArticleId IdType="pmc">1327899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castleman B, Mallory TB (1935) The pathology of the parathyroid gland in hyperparathyroidism. Am J Pathol 11:1–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19970186</ArticleId>
            <ArticleId IdType="pmc">1910762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGregor DH, Lotuaco LG, Rao MS, Chu LL (1978) Functioning oxyphil adenoma of parathyroid gland. An ultrastructural and biochemical study. Am J Pathol 92(3):691–711</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">686153</ArticleId>
            <ArticleId IdType="pmc">2018274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christie AC (1967) The parathyroid oxyphil cells. J clin Path 20:591</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.20.4.591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremblay G, Cartier GE (1961) Histochemical study of oxidative enzymes in the human parathyroid. Endocrinol 69:658–61</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endo-69-3-658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen TB, Thorburn KM (1981) The oxyphil cell in abnormal parathyroid glands. Arch Pathol Lab Med 105:421–427</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6894851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritter CS, Haughey BH, Miller B, Brown AJ (2012) Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 97(8):1499–1505</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2011-3366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howson P, Kruijff S, Aniss A, Pennington T, Gill AJ, Dodds T et al (2015) Oxyphil cell parathyroid adenomas causing primary hyperparathyroidism: a clinico-pathological correlation. Endocr Pathol 26(3):250–254</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12022-015-9378-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 34(1):24–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8418265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ et al (1998) Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 39(8):1441–1444</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9708524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erbil Y, Kapran Y, Işsever H, Barbaros U, Adalet I, Dizdaroǧlu F et al (2008) The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 195(1):34–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjsurg.2007.01.040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takebayashi S, Hidai H, Chiba T, Takagi Y, Nagatani Y, Matsubara S (1999) Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40(11):1792–1797</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10565772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S et al (1997) Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 24(2):143–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02439546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedetti CD, Dekker A, Watson CG (1984) Functioning oxyphil cell adenoma of the parathyroid gland: a clinicopathologic study of ten patients with hyperparathyroidism. Hum Pathol 15(12):1121–6. https://doi.org/10.1016/S0046-8177(84)80306-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0046-8177(84)80306-8</ArticleId>
            <ArticleId IdType="pubmed">6389314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolpert HR, Vickery AL, Wang CA (1989) Functioning oxyphil adenomas. Am J Surg Pathol 13(6):500–504</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000478-198906000-00006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta NY, Ruda JM, Kapadia S, Boyer PJ, Hollenbeak CS, Stack BC (2005) Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol - Head Neck Surg 131(6):493–498</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archotol.131.6.493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30(5):697–704</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00268-005-0338-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ (2012) Distribution and regulation of the 25-hydroxyvitamin D 3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 130(1–2):73–80. https://doi.org/10.1016/j.jsbmb.2012.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2012.01.010</ArticleId>
            <ArticleId IdType="pubmed">22326730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westreich RW, Brandwein M, Mechanick JI, Bergman DA, Urken ML (2003) Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope 113(3):567–572</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005537-200303000-00032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishibashi M, Nishida H, Strauss HW, Kojima K, Fujito H, Watanabe J (1997) Localization of parathyroid glands using technetium-99m-tetrofosmin imaging. J Nucl Med 38(5):706–711</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9170432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28(2):209–213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002590000406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bleier BS, LiVolsi VA, Chalian AA, Gimotty PA, Botbyl JD, Weber RS (2006) Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol - Head Neck Surg 132(7):779–782</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archotol.132.7.779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD et al (2007) Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 142(4):381–386</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archsurg.142.4.381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y et al (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139(11):1175–1179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archsurg.139.11.1175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cermik TF, Puyan FO, Sezer A, Firat MF, Berkarda S (2005) Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med 19(5):387–392</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03027403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dugonjić S, Cerović S, Janković Z, Ajdinović B (2012) Korelacija nalaza suptrakcione scintigrafije paratiroidnih žlezda liposolubilnim radiofarmacima sa veličinom, patohistološkim nalazom i procentom oksifilnih ćelija kod bolesnika sa hiperplazijom paratiroidnih žlezda. Vojnosanit Pregl 69(4):345–352</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2298/VSP1204345D</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundgren E, Ridefelt P, Åkerström G, Ljunghall S, Rastad J (1996) Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening. World J Surg 20(7):727–735</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002689900111</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
